Literature DB >> 28870909

Expression of Cancer Stem Cell-associated DKK1 mRNA Serves as Prognostic Marker for Hepatocellular Carcinoma.

Tomohiko Sakabe1,2, Junya Azumi1, Yoshihisa Umekita2, Kan Toriguchi3, Etsuro Hatano3, Yasuaki Hirooka4, Goshi Shiota5.   

Abstract

BACKGROUND/AIM: Cancer stem cells (CSCs) are associated with prognosis of hepatocellular carcinoma (HCC). In our previous study, we created cDNA microarray databases on the CSC population of human HuH7 cells. In the present study, we identified genes that might serve as prognostic markers of HCC by employing existing databases.
MATERIALS AND METHODS: Expressions of glutathione S-transferase pi 1 (GSTP1), lysozyme (LYZ), C-X-C motif chemokine ligand 5 (CXCL5), interleukin-8 (IL8) and dickkopf WNT signaling pathway inhibitor 1 (DKK1), the five most highly expressed genes in the CSC cDNA microarray databases, were examined in 99 patients with HCC by real-time polymerase chain reaction (qRT-PCR), and their clinical significance was analyzed.
RESULTS: The Kaplan-Meier analysis showed that both overall and cancer-specific survival were significantly longer in patients with low DKK1 expression than in those with high DKK1 expression. The multivariate analysis revealed that overall survival was negatively associated with albumin and positively associated with alkaline phosphatase (ALP), serosal invasion and stage, and cancer-specific survival was positively associated with ALP, portal vein invasion and DKK1 mRNA.
CONCLUSION: Expression of CSC-associated DKK1 mRNA might be an unfavorable prognostic marker for patients with HCC. Copyright
© 2017, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  CD44; DKK1; cancer stem cells; hepatocellular carcinoma; prognosis

Mesh:

Substances:

Year:  2017        PMID: 28870909     DOI: 10.21873/anticanres.11897

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  10 in total

1.  Hepatocellular Carcinoma-associated microRNAs Induced by Hepatoma-derived Growth Factor Stimulation.

Authors:  Hirayuki Enomoto; Hideji Nakamura; Hiroki Nishikawa; Takashi Nishimura; Yoshinori Iwata; Shuhei Nishiguchi; Hiroko Iijima
Journal:  In Vivo       Date:  2020 Sep-Oct       Impact factor: 2.155

Review 2.  CYP3A4 Gene Is a Novel Biomarker for Predicting a Poor Prognosis in Hepatocellular Carcinoma.

Authors:  Ryo Ashida; Yukiyasu Okamura; Keiichi Ohshima; Yuko Kakuda; Katsuhiko Uesaka; Teiichi Sugiura; Takaaki Ito; Yusuke Yamamoto; Takashi Sugino; Kenichi Urakami; Masatoshi Kusuhara; Ken Yamaguchi
Journal:  Cancer Genomics Proteomics       Date:  2017 Nov-Dec       Impact factor: 4.069

3.  Identification of biomarkers for Barcelona Clinic Liver Cancer staging and overall survival of patients with hepatocellular carcinoma.

Authors:  Wei Xu; Quan Rao; Yongbo An; Mengyi Li; Zhongtao Zhang
Journal:  PLoS One       Date:  2018-08-23       Impact factor: 3.240

Review 4.  New prognostic biomarkers of mortality in patients undergoing liver transplantation for hepatocellular carcinoma.

Authors:  Leonardo Lorente
Journal:  World J Gastroenterol       Date:  2018-10-07       Impact factor: 5.742

5.  Diagnostic accuracy of serum dickkopf-1 protein in diagnosis hepatocellular carcinoma: An updated meta-analysis.

Authors:  Zhenjie Li; Lisha Mou; Haibin Gao; Yi Zeng; Xueyi Tang; Xuesong Deng; Zuhui Pu; Yong Ni; Yongqiang Zhan
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.817

Review 6.  Proteomic Profiling and Artificial Intelligence for Hepatocellular Carcinoma Translational Medicine.

Authors:  Nurbubu T Moldogazieva; Innokenty M Mokhosoev; Sergey P Zavadskiy; Alexander A Terentiev
Journal:  Biomedicines       Date:  2021-02-06

7.  Dickkopf-1 Promotes Angiogenesis and is a Biomarker for Hepatic Stem Cell-like Hepatocellular Carcinoma.

Authors:  Tsuyoshi Suda; Taro Yamashita; Hajime Sunagozaka; Hikari Okada; Kouki Nio; Yoshio Sakai; Tatsuya Yamashita; Eishiro Mizukoshi; Masao Honda; Shuichi Kaneko
Journal:  Int J Mol Sci       Date:  2022-03-03       Impact factor: 5.923

Review 8.  Novel biomarkers for the management of chronic hepatitis B.

Authors:  Takako Inoue; Yasuhito Tanaka
Journal:  Clin Mol Hepatol       Date:  2020-06-15

9.  The association between pretreatment serum alkaline phosphatase and prognosis in hepatocellular carcinoma: A meta-analysis.

Authors:  Ping Sun; Shihai Chen; Yanlong Li
Journal:  Medicine (Baltimore)       Date:  2020-03       Impact factor: 1.817

Review 10.  CXCL5/CXCR2 axis in tumor microenvironment as potential diagnostic biomarker and therapeutic target.

Authors:  Wen Zhang; Huishan Wang; Mingyang Sun; Xueting Deng; Xueru Wu; Yilan Ma; Mengjing Li; Said Maisam Shuoa; Qiang You; Lin Miao
Journal:  Cancer Commun (Lond)       Date:  2020-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.